- Previous Close
122.65 - Open
123.31 - Bid 125.71 x 800
- Ask 125.97 x 800
- Day's Range
122.76 - 126.72 - 52 Week Range
75.83 - 171.20 - Volume
233,820 - Avg. Volume
1,374,625 - Market Cap (intraday)
11.945B - Beta (5Y Monthly) 2.15
- PE Ratio (TTM)
3.98 - EPS (TTM)
31.57 - Earnings Date Feb 6, 2025 - Feb 10, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 13, 2000
- 1y Target Est
179.46
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; quaternary care services in heart and kidney transplants; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services, such as orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. It operates hospitals, ambulatory surgery centers, imaging centers, surgical hospitals, off-campus emergency departments, and micro-hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas.
www.tenethealth.com78,810
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: THC
View MorePerformance Overview: THC
Trailing total returns as of 1/6/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: THC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: THC
View MoreValuation Measures
Market Cap
11.66B
Enterprise Value
20.44B
Trailing P/E
3.89
Forward P/E
10.32
PEG Ratio (5yr expected)
0.57
Price/Sales (ttm)
0.58
Price/Book (mrq)
3.04
Enterprise Value/Revenue
0.97
Enterprise Value/EBITDA
3.00
Financial Highlights
Profitability and Income Statement
Profit Margin
14.91%
Return on Assets (ttm)
6.99%
Return on Equity (ttm)
59.56%
Revenue (ttm)
20.97B
Net Income Avi to Common (ttm)
3.13B
Diluted EPS (ttm)
31.57
Balance Sheet and Cash Flow
Total Cash (mrq)
4.09B
Total Debt/Equity (mrq)
159.39%
Levered Free Cash Flow (ttm)
3.38B